
|Videos|February 1, 2021
Misinformation and Its Impact on COVID-19 Vaccine Distribution
Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on how communicating the safety and efficacy of COVID-19 vaccines to the public is an essential piece of the rollout.
Advertisement
Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on how communicating the safety and efficacy of coronavirus disease 2019 (COVID-19) vaccines to the public is an essential piece of the rollout.
For the full conversation, see the video above.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Five-Year NATALEE Data Show Ribociclib Improves Outcomes in High-Risk HR+/HER2– Early Breast Cancer
2
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
3
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
4
Under Pressure: A Brief Overview of the Updated Hypertension Guidelines
5